COVID-19 Update

As the global impacts of COVID-19 evolve, Novocure® is taking proactive steps to protect and support the health and well-being of our colleagues, our patients and caregivers, and all of our partners, while we continue to deliver our therapy to patients in need. Learn more.

Treatment for glioblastoma (GBM)
Intended for US audiences only.

Events throughout the year help you to stay inspired and informed.

Open House Events

Optune Open Houses are live and virtual educational events happening throughout the year where you can:

  • Learn more about glioblastoma and Optune
  • Hear firsthand from Optune users and caregivers about starting and incorporating Optune into daily life.

You can also have a chance to ask questions and discuss other topics about Optune.

Go to OptuneOpenHouse.com to register for an Optune Open House today.

To find out more or register over the phone, call 1-855-281-9301 for live events or 1-844-247-1636 for Webinars.

See what an Optune Open House is like.

Live events

Webinars

August 13, 2020

August night-time Webinar

OptuneOpenHouse.com

7:00 PM EST

To RSVP, call 1-844-247-1636

August 27, 2020

August day-time webinar

OptuneOpenHouse.com

12:00 PM EST

To RSVP, call 1-844-247-1636

September 10, 2020

September night-time Webinar

OptuneOpenHouse.com

7:00 PM EST

To RSVP, call 1-844-247-1636

September 24, 2020

September day-time webinar

OptuneOpenHouse.com

12:00 PM EST

To RSVP, call 1-844-247-1636

What is Optune® approved to treat?

Optune is a wearable, portable, FDA-approved device indicated to treat a type of brain cancer called glioblastoma multiforme (GBM) in adult patients 22 years of age or older.

Newly diagnosed GBM

If you have newly diagnosed GBM, Optune is used together with a chemotherapy called temozolomide (TMZ) if:

Recurrent GBM

If your tumor has come back, Optune can be used alone as an alternative to standard medical therapy if:

Who should not use Optune?

Optune is not for everyone. Talk to your doctor if you have:

Do not use Optune if you are pregnant or are planning to become pregnant. It is not known if Optune is safe or effective during pregnancy.

What should I know before using Optune?

Optune should only be used after receiving training from qualified personnel, such as your doctor, a nurse, or other medical staff who have completed a training course given by Novocure®, the maker of Optune.

What are the possible side effects of Optune?

Most common side effects of Optune when used together with chemotherapy (temozolomide, or TMZ) were low blood platelet count, nausea, constipation, vomiting, tiredness, scalp irritation from the device, headache, seizure, and depression.

The most common side effects when using Optune alone were scalp irritation (redness and itchiness) and headache. Other side effects were malaise, muscle twitching, fall and skin ulcers.

Talk to your doctor if you have any of these side effects or questions.


Please click here to see the Optune Instructions for Use (IFU) for complete information regarding the device's indications, contraindications, warnings, and precautions.

On this site, patient and healthcare professional videos as well as all images labeled as Optune users, caregivers, or healthcare professionals depict actual patients, caregivers, and healthcare professionals. All other depictions of patients and caregivers are actor portrayals. Patient images reflect the health status of the patients at the time each photo was taken.

What is Optune approved to treat?

Optune is indicated to treat a type of brain cancer called glioblastoma multiforme (GBM) in adult patients 22 years of age or older.